535 related articles for article (PubMed ID: 21864953)
1. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
[TBL] [Abstract][Full Text] [Related]
2. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073
[TBL] [Abstract][Full Text] [Related]
3. Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study.
Frison L; Lombardi A; Caputo I; Semenzato G; Fabris F; Vianello F
Hematology; 2019 Dec; 24(1):134-138. PubMed ID: 30355275
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
Diz-Küçükkaya R; Hacihanefioğlu A; Yenerel M; Turgut M; Keskin H; Nalçaci M; Inanç M
Blood; 2001 Sep; 98(6):1760-4. PubMed ID: 11535509
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
6. Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.
Moulis G; Audemard-Verger A; Arnaud L; Luxembourger C; Montastruc F; Gaman AM; Svenungsson E; Ruggeri M; Mahévas M; Gerfaud-Valentin M; Brainsky A; Michel M; Godeau B; Lapeyre-Mestre M; Sailler L
Autoimmun Rev; 2016 Mar; 15(3):203-9. PubMed ID: 26708169
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
8. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
11. The Italian Registry of Antiphospholipid Antibodies.
Finazzi G
Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
[TBL] [Abstract][Full Text] [Related]
12. Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature.
El-Gendy H; El-Gohary RM; Mahfouz S; Ahmed HMA; El Demerdash DM; Ragab G
Platelets; 2019; 30(5):664-671. PubMed ID: 30373491
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
[TBL] [Abstract][Full Text] [Related]
18. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies.
Owaidah TM; Qurashi FH; Al Nounou RM; Al Zahrani H; Al Mussa A; Tbakhi AI; Al Daama S; Elkum N; Roberts GT
Hematology; 2003 Aug; 8(4):249-57. PubMed ID: 12911943
[TBL] [Abstract][Full Text] [Related]
19. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
